Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy

Erstveröffentlichung
2016Authors
Herling, Carmen Diana
Klaumuenzer, Marion
Rocha, Cristiano Krings
Altmueller, Janine
Thiele, Holger
Wissenschaftlicher Artikel
Published in
Blood ; 128 (2016), 3. - S. 395-404. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood-2016-01-691550Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: chronic lymphocytic-leukemia | identifies recurrent mutations | chromosomal translocations | genetic-characterization | metaphase cytogenetics | independent predictor | genomic aberrations | telomere length | splicing factor | poor-prognosis[DDC subject group]: DDC 610 / Medicine & health